Synthesis, Antibacterial and Analgesic Activities
61
added 4 (8.9 g, 0.05 mol). The mixture was heated to reflux while being stirred. Glacial
acetic acid (2.9 mL, 0.05 mol) was added drop wise through a dropping funnel over a period
of 10 min. The stirred reaction mixture was heated for 5 h. After cooling to room
temperature, the benzene was decanted and the remaining black residue was extracted twice
with 20 mL benzene. Combined extract were evaporated to dryness to yield 5 (5.6 g, 0.025
o
mol, 51%) and it was recrystallised from aqueous alcohol. M.p 82-84 C; IR, cm-1 1759
1
(C=O, sydnone), 1668 (COCH3); H-NMR, δ ppm 2.50 (s, 3H, CH3), 2.56 (s, 3H, COCH3),
7.33-7.63 (m, 4H, Ar-H)
General procedure for synthesis of 6a-g
Synthesis of 4-[1-oxo-3-(3,4,5-trimethoxy phenyl)-2-propenyl]-3-(4-methylphenyl)
sydnone(6d)
A mixture of 5 (0.22 g, 0.001 mol), sodium hydroxide aqueous solution (0.06 g,
0
0.0015 mol, 0.3 mL) and ethanol (95%, 2 mL) was cooled (5-10 C) and to this was added
with 3,4,5-trimethoxybenzaldehyde (0.3 g, 0.0015 mol) while being stirred. The reaction
mixture was stirred further for 1 h. The precipitated 6d was filtered washed thoroughly with
cold water and recrystallised from ethanol (95%) and ethyl acetate (1:1) mixture, Yield 63%.
0
M.p. 116-118 C; IR, cm-1 1753 (C=O, sydnone), 1675 (C=O, styryl ketone); 1H NMR, δ ppm
2.46 (s, 3H, CH3), 3.92 (s, 9H, OCH3 ), 6.8 (d, 1H, α olefinic), 7.81 (d, 1H, β olefinic), 7.11-
7.6 (m, 6H, Ar-H). 6c: 1H NMR, δ ppm 2.49 (s, 3H, CH3), 6.76 (d, 1H, α olefinic), 7.39-7.63
(m, 9H, Ar-H and β olefinic) 6a: MS, m/z 306 (M+). Rests of the compounds were
synthesized in the similar fashion.
General procedure for Synthesis of 6h-i
Synthesis of 4-[1-oxo-3- (4-hydroxy-3-methoxyphenyl)-2-propenyl]-3-(4-methylphenyl)
sydnone (6h)
Into the suspension of 5 (0.22 g, 0.001 mol) and vanillin (0.15 g, 0.001 mol) in 2 mL of ethanol
0
(95%) dry hydrogen chloride gas was passed for 0.5 h under cooling condition (5 C). The
reaction mixture was left overnight at room temperature and poured into cold water. The
separated 6h was filtered, washed, dried in air and recrystallised from ethanol (95%).Yield 55%.
o
M.p 211-213 C; IR, cm-1 1760 (C=O, sydnone), 1649 (C=O, styryl ketone); 1H NMR, δ ppm
2.45 (s, 3H, CH3), 3.93 (s, 3H, OCH3), 7.0-7.7 (m, 9H, Ar-H and olefinic), 9.89 (s, 1H, OH).
Compound 6i was synthesized in the similar fashion.
Biological activity
The compounds 6a-i were screened for preliminary antibacterial activity by Cup Plate method15
at 10, 20 and 50 µg in DMSO against Staphylococcus aureus, Bacillus subtilis (Gram-positive)
and Escherichia coli, Salmonella typhi (Gram-negative) grown on nutrient agar medium and the
diameter of zone of inhibition was taken as a measure of antibacterial activity; norfloxacin at 20
µg concentration was employed as standard drug. The newly synthesized compounds were
tested for acute toxicity studies in mice16 and then screened for analgesic activity by acetic acid
induced writhing in mice17 at 100 mg/kg b.w.; aspirin at 100 mg/kg b.w. was used as standard
drug and percentage inhibition of writhes was calculated to assess the analgesic activity.
Results and Discussion
3-(4-Methylphenyl) sydnone (4) was prepared according to reported method18 wherein, 4-toluidine
was condensed with ethyl chloroacetate in presence of anhydrous sodium acetate to give
ethyl ester of N- (4-methylphenyl) glycine (1), which upon hydrolysis with sodium hydroxide